2024
Efficacy of Voluntary Medical Male Circumcision to Prevent HIV Infection Among Men Who Have Sex With Men : A Randomized Controlled Trial.
Gao Y, Zhan Y, Sun Y, Zheng W, Zhang W, Fu L, Guo Z, Lin Y, Li Y, Zheng L, Zhan Y, Zhu Z, Duan J, Zhang G, Huang T, Su B, Yu M, Wu G, Ouyang L, Zhao J, Wang G, Zhou Y, Qian H, Fitzpatrick T, Vermund S, Zou H. Efficacy of Voluntary Medical Male Circumcision to Prevent HIV Infection Among Men Who Have Sex With Men : A Randomized Controlled Trial. Annals Of Internal Medicine 2024, 177: 719-728. PMID: 38801778, DOI: 10.7326/m23-3317.Peer-Reviewed Original ResearchVoluntary medical male circumcisionEfficacy of VMMCPreventing incident HIV infectionsRandomized controlled trialsMedical male circumcisionIncident HIV infectionIntervention groupInsertive anal intercoursePractice insertive anal intercourseMale circumcisionAnal intercourseIncidence rate of syphilisHIV infectionRates of syphilisMale sex partnersSexually transmitted infectionsIntention-to-treat analysisPrevent HIV infectionHIV incidenceControl groupHIV riskIncidence rateHerpes simplex virus type 2HIV seroconversionSelf-report
2018
Assessing Individual and Disseminated Effects in Network-Randomized Studies
Buchanan AL, Vermund SH, Friedman SR, Spiegelman D. Assessing Individual and Disseminated Effects in Network-Randomized Studies. American Journal Of Epidemiology 2018, 187: 2449-2459. PMID: 30052722, PMCID: PMC6211234, DOI: 10.1093/aje/kwy149.Peer-Reviewed Original Research
2014
Efficacy of Peer-Led Interventions to Reduce Unprotected Anal Intercourse among Men Who Have Sex with Men: A Meta-Analysis
Ye S, Yin L, Amico R, Simoni J, Vermund S, Ruan Y, Shao Y, Qian HZ. Efficacy of Peer-Led Interventions to Reduce Unprotected Anal Intercourse among Men Who Have Sex with Men: A Meta-Analysis. PLOS ONE 2014, 9: e90788. PMID: 24614809, PMCID: PMC3948720, DOI: 10.1371/journal.pone.0090788.Peer-Reviewed Original ResearchConceptsPost-intervention studyUnprotected anal intercourseCross-sectional intervention studyPeer-led interventionsStandardized mean differenceIntervention studiesQuasi-experimental studyAnal intercourseHIV prevention interventionsCross-sectional assessmentNon-significant reductionPre-post interventionEffect sizeMore RCTsSubgroup analysisClinical trialsPrevention interventionsEligibility criteriaControl groupElectronic databasesSystematic reviewMeta-AnalysisSexual partnersMean differenceRCTs
2007
Syndromic management training for non-formal care providers in Pakistan improves quality of care for sexually transmitted diseases STD care: a randomized clinical trial.
Shah SA, Kristensen S, Memon MA, White HL, Vermund SH. Syndromic management training for non-formal care providers in Pakistan improves quality of care for sexually transmitted diseases STD care: a randomized clinical trial. The Southeast Asian Journal Of Tropical Medicine And Public Health 2007, 38: 737-48. PMID: 17883016.Peer-Reviewed Original ResearchConceptsSTD careIntervention groupCare providersControl groupRandomized clinical trialsThree-armed trialQuality of careCase management servicesSTD servicesSyndromic managementClinical trialsCondom provisionCondom useNon-formal providersExit interviewsCareTrialsGroupProvidersService deliveryManagement trainingPatientsReferralMore knowledgeMonths
2002
Lack of Effect of Chlorhexidine Varnish on Streptococcus mutans Transmission and Caries in Mothers and Children
Dasanayake AP, Wiener HW, Li Y, Vermund S, Caufield PW. Lack of Effect of Chlorhexidine Varnish on Streptococcus mutans Transmission and Caries in Mothers and Children. Caries Research 2002, 36: 288-293. PMID: 12218279, DOI: 10.1159/000063922.Peer-Reviewed Original ResearchConceptsChlorhexidine varnishSalivary S. mutans levelsChild's fourth birthdayRandomized clinical trialsS. mutans levelsMother-child pairsFourth birthdayMother-child transmissionS. mutans colonizationLack of effectCaries experienceMutans levelsPlacebo varnishClinical trialsFirst babyTreatment groupsControl groupWeekly intervalsCariesMothersChildrenMonthsStreptococcus mutansGroupBabies
1998
Analysis of Intercurrent Human Immunodeficiency Virus Type 1 Infections in Phase I and II Trials of Candidate AIDS Vaccines
Graham B, McElrath M, Connor R, Schwartz D, Gorse G, Keefer M, Mulligan M, Matthews T, Wolinsky S, Montefiori D, Vermund S, Lambert J, Corey L, Belshe R, Dolin R, Wright P, Korber B, Wolff M, Fast P, Group A. Analysis of Intercurrent Human Immunodeficiency Virus Type 1 Infections in Phase I and II Trials of Candidate AIDS Vaccines. The Journal Of Infectious Diseases 1998, 177: 310-309. PMID: 9466516, DOI: 10.1086/514209.Peer-Reviewed Original ResearchMeSH KeywordsAdultAIDS VaccinesAmino Acid SequenceCD4 Lymphocyte CountFemaleHIV AntibodiesHIV Envelope Protein gp120HIV InfectionsHIV-1HumansImmunity, ActiveIncidenceMaleMiddle AgedMolecular Sequence DataNeutralization TestsPeptide FragmentsRisk-TakingSequence AnalysisSubstance Abuse, IntravenousViral LoadConceptsHIV-1 infectionHuman immunodeficiency virus type 1 (HIV-1) infectionVirus type 1 infectionCandidate AIDS vaccinesType 1 infectionAIDS vaccinePhase IHigh-risk sexual exposureVaccine-induced immune responsesComplete immunization scheduleEarly clinical courseCD4 lymphocyte countIntravenous drug useV3 loop amino acid sequencesUninfected subjectsVaccine recipientsLymphocyte countClinical courseImmunization scheduleSexual exposureVirus loadImmune responseControl groupDrug useInfection